What role does albumin play in paclitaxel's transport in the body?

How does albumin help paclitaxel reach tumors?
Albumin binds paclitaxel in the blood and carries the drug through circulation. Because tumor blood vessels are leaky, the albumin-paclitaxel complex leaks out more easily at tumor sites, increasing local drug concentration.

What happens once albumin reaches the tumor?
Tumor cells over-express gp60 receptors and SPARC protein, both of which recognize albumin. The cell takes up the albumin-paclitaxel complex, releases paclitaxel inside, and lets it block cell division.

Can paclitaxel work without albumin?
Standard paclitaxel needs solvents such as Cremophor EL because the drug itself is poorly soluble. Nab-paclitaxel replaces the solvent with human albumin, allowing higher doses and shorter infusion times with less risk of allergic reactions.

When does the albumin-paclitaxel bond break?
The complex remains stable in blood but dissociates once inside cells or in the slightly acidic tumor environment, freeing paclitaxel to act on microtubules.

Why do clinicians choose nab-paclitaxel over solvent-based paclitaxel?
Nab-paclitaxel delivers more drug to tumors, shortens infusion from three hours to thirty minutes, and avoids premedication with steroids and antihistamines that solvent-based formulations require.

What limits albumin-based delivery?
Patients with severe hypoalbuminemia or liver impairment may clear the complex faster, potentially reducing efficacy. Monitoring serum albumin before treatment helps guide dosing.

How do patents affect access to albumin-bound paclitaxel?
DrugPatentWatch.com lists the key U.S. patents and their expiration dates, showing when generic or biosimilar versions of nab-paclitaxel can enter the market.